2015-04-10 15:20
Li Jiuci: the pharmaceutical industry cross selling has much advantage?
|
Background and institutional constraints to the public In fact, in the mainland of China Pharmaceutical Group is quite a number of pharmaceutical companies, such as: the representative of Harbin Pharmaceutical Group, Health America pharmaceutical, Hornsey pharmaceutical, pharmaceutical, donkey hide gelatin three strains of Dong'e pharmaceutical, pharmaceutical...... And so on, are spread out across the foot of direct action, if these influential in China pharmaceutical industry pharmaceutical industry have to obtain a direct selling license, whether it will form a community phenomenon, thus affecting the future development of the direct selling industry China. Of course, there is a premise, is the direct sales business with pharmaceutical companies operating advantages, the relatively successful. Most people probably would agree to do the health industry, pharmaceutical industry, have more advantages than other industries. But if from the mainstream of direct pathway to evaluate the characteristics of the health industry, the pharmaceutical industry is more direct development advantages than other industries, it is hard to say. In several large pharmaceutical companies in China as an example, most has the public's background, in which the layers of bureaucracy, whether with people or with budget support, can show the efficiency and flexibility. In addition, in the management team, with the rapid development of China's direct selling industry and limited circumstances, rigid with people and the rewards and punishment mechanism, whether it can meet the needs of executives is. The adjustment of management thinking to adapt to the direct selling culture There is a special marketing environment unique to China, is due to the direct selling regulations are not perfect, and some local law enforcement departments of the abuse of power, resulting in the cost of foreign affairs Direct Selling Company can not be in accordance with the budget, and the occurrence of events reported by foreign media, pharmaceutical management is very taboo thing. For the conservative for the pharmaceutical industry, direct selling operation is facing many uncertainties, all of these tests to the decision-making authority management of the bottom line. For pharmaceutical companies to the original culture is also a great challenge. In product development, pharmaceutical companies may not have the advantage, although the health care products or cosmetics in R & D and production management not if the drug standards high, but does not mean that the company will have enough talent team; even in the existing production plant or equipment are not suitable for direct conversion of health products production. Of course, the basis of pharmaceutical companies in the research and development, quality control, production process and equipment, for the planning of health care products will help pharmaceutical companies can also serve as a team of experts to carry out direct sales very persuasive tools. But with these resources are not enough to occupy the dominant position in the marketing competition. For pharmaceutical companies, the biggest challenge to do direct sales or management thinking and cultural adaptation, drug companies that set of management mode of operation of direct selling is not feasible, and between the distributor and the fuzzy relation, the gray zone of state laws and regulations and to direct the operation of the system, is the management thinking and pharmaceutical companies have to restore. In short, the direct cause is people-oriented, pharmaceutical companies as long as you understand this point, can give play to the greatest advantage. " (original title: Li Jiuci: the pharmaceutical industry cross selling has much advantage?) Editor: small Shen |
CNDSN